Literature DB >> 15735257

Interaction between voriconazole and tacrolimus in a kidney-transplanted patient.

Michel Tintillier, Lotti Kirch, Eric Goffin, Charles Cuvelier, Jean-Michel Pochet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735257     DOI: 10.1093/ndt/gfh593

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.

Authors:  Kelong Han; Robert Bies; Heather Johnson; Blair Capitano; Raman Venkataramanan
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

2.  Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.

Authors:  E M Billaud; C Antoine; M Berge; I Abboud; S Lefeuvre; M Benammar; D Glotz
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 3.  Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective.

Authors:  Michel Laverdiere; Eric J Bow; Coleman Rotstein; Julie Autmizguine; Raewyn Broady; Gary Garber; Shariq Haider; Trana Hussaini; Shahid Husain; Philippe Ovetchkine; Jack T Seki; Yves Théorêt
Journal:  Can J Infect Dis Med Microbiol       Date:  2014 Nov-Dec       Impact factor: 2.471

4.  Successful treatment of Talaromyces marneffei pneumonia in a HIV-negative renal transplantation recipient: A case report.

Authors:  De-Han Cai; Jun Wang; Xiao-Lin Fang
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

5.  Voriconazole pharmacokinetics in liver transplant recipients.

Authors:  H J Johnson; Kelong Han; B Capitano; D Blisard; S Husain; P K Linden; A Marcos; E J Kwak; B Potoski; D L Paterson; M Romkes; R Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.